Genzyme Corporation
Manufacturer / marketing-authorisation holder
Genzyme Corporation — 25 products across 2 markets, 18 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.
Genzyme Corporation — 25 productos en 2 mercados, 18 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.
Genzyme Corporation —— 共 25 个产品,覆盖 2 个市场、18 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。
25 products · 2 markets · 18 brand names
25 productos · 2 mercados · 18 marcas
25 个产品 · 2 个市场 · 18 个品牌名
Products by country
US
Source: api.fda.gov
| Brand | Active ingredient(s) | Form |
|---|---|---|
| ALDURAZYME | Laronidase | injection |
| Aubagio | 特立氟胺 | tablet |
| Aubagio | 特立氟胺 | tablet |
| CAPRELSA | Vandetanib | tablet |
| CAPRELSA | Vandetanib | tablet |
| Cablivi | Ingredient not recorded (name-level) | kit |
| Campath | Alemtuzumab | injection |
| Cerdelga | Eliglustat | capsule |
| Cerezyme | 伊米苷酶 | injection |
| Fabrazyme | Agalsidase Beta | injection |
| Fabrazyme | Agalsidase Beta | injection |
| LEMTRADA | Alemtuzumab | injection |
| Lumizyme | 阿糖苷酶α | injection |
| Nexviazyme | Avalglucosidase Alfa | injection |
| Qfitlia | Fitusiran | injection |
| Qfitlia | Fitusiran | injection |
| Renvela | Sevelamer Carbonate | tablet |
| Renvela | Sevelamer Carbonate | powder |
| Renvela | Sevelamer Carbonate | powder |
| Thymoglobulin | Lapine T Lymphocyte Immune Globulin | injection |
| Thyrogen | Thyrotropin Alfa | injection |
| WAYRILZ | Rilzabrutinib | tablet |
| XENPOZYME | Olipudase Alfa | injection |
| XENPOZYME | Olipudase Alfa | injection |
CA
Source: health-products.canada.ca
| Brand | Active ingredient(s) | Form |
|---|---|---|
| MABCAMPATH | Alemtuzumab | liquid |